RAR-related orphan receptor
| RAR-related orphan receptor A (alpha)
| |
| Identifiers | |
| Symbol | RORA |
| Alt. Symbols | RZRA, ROR1, ROR2, ROR3, NR1F1 |
| Entrez | 6095 |
| HUGO | 10258 |
| OMIM | 600825 |
| PDB | 1N83 |
| RefSeq | NM_002943 |
| UniProt | P35398 |
| Other data | |
| Locus | Chr. 15 q21-q22 |
| RAR-related orphan receptor B (beta)
| |
| Identifiers | |
| Symbol | RORB |
| Alt. Symbols | RZRB, NR1F2, ROR-BETA |
| Entrez | 6096 |
| HUGO | 10259 |
| OMIM | 601972 |
| PDB | 1NQ7 |
| RefSeq | NM_006914 |
| UniProt | Q92753 |
| Other data | |
| Locus | Chr. 9 q22 |
| RAR-related orphan receptor C (gamma)
| |
| Identifiers | |
| Symbol | RORC |
| Alt. Symbols | RZRG, RORG, NR1F3, TOR |
| Entrez | 6097 |
| HUGO | 10260 |
| OMIM | 602943 |
| RefSeq | NM_005060 |
| UniProt | P51449 |
| Other data | |
| Locus | Chr. 1 q21 |
The RAR-related orphan receptors (RORs) are members of the nuclear receptor family of intracellular transcription factors.[1][2] There are three forms of ROR, ROR-α, -β, and -γ and each is encoded by a separate gene (RORA, RORB, and RORC respectively). The RORs are somewhat unusual in that they appear to bind as monomers to hormone response elements as opposed to the majority of other nuclear receptors which bind as dimers.[3]
Melatonin is reported to be the endogenous ligand for ROR-α[4] In contrast, all-trans retinoic acid binds with high affinity to ROR-β but not ROR-α or -γ.[5]
The three forms of RORs fulfill a number of critical roles[6] including:
- ROR-α - development of the cerebellum, maintenance of bone, lymph node development, immune response
- ROR-β
- ROR-γ - immune response
References
- ↑ Giguère V, Tini M, Flock G, Ong E, Evans RM, Otulakowski G (1994). "Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors". Genes Dev. 8 (5): 538-53. doi:10.1101/gad.8.5.538. PMID 7926749.
- ↑ Hirose T, Smith RJ, Jetten AM (1994). "ROR gamma: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle". Biochem. Biophys. Res. Commun. 205 (3): 1976-83. doi:10.1006/bbrc.1994.2902. PMID 7811290.
- ↑ Jetten AM, Kurebayashi S, Ueda E (2001). "The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes". Prog. Nucleic Acid Res. Mol. Biol. 69: 205-47. PMID 11550795.
- ↑ Wiesenberg I, Missbach M, Kahlen JP, Schräder M, Carlberg C (1995). "Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand". Nucleic Acids Res. 23 (3): 327-33. doi:10.1093/nar/23.3.327. PMID 7885826.
- ↑ Stehlin-Gaon C, Willmann D, Zeyer D, Sanglier S, Van Dorsselaer A, Renaud JP, Moras D, Schüle R (2003). "All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta". Nat. Struct. Biol. 10 (10): 820-5. doi:10.1038/nsb979. PMID 12958591.
- ↑ Jetten AM (2004). "Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs)". Current drug targets. Inflammation and allergy 3 (4): 395-412. PMID 15584888.
External links
- MeSH RAR-related+orphan+receptor+A
- MeSH RAR-related+orphan+receptor+B
- MeSH RAR-related+orphan+receptor+C
Transcription factors and intracellular receptors | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (1) Basic domains |
| ||||||||||||
| (2) Zinc finger DNA-binding domains |
| ||||||||||||
| (3) Helix-turn-helix domains |
| ||||||||||||
| (4) β-Scaffold factors with minor groove contacts |
| ||||||||||||
| (0) Other transcription factors |
| ||||||||||||
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies